Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
2.32M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-16.9K
-
Total reported value, excl. options
-
$0
-
Value change
-
-$176K
-
Number of sells
-
-1
Significant Holders of Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) as of Q4 2023
1 filings reported holding BLAC - Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share as of Q4 2023.
Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 2.32M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include Polar Asset Management Partners Inc. (260K shares), Saba Capital Management, L.P. (250K shares), AQR Arbitrage LLC (250K shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (245K shares), Schechter Investment Advisors, LLC (211K shares), Exos TFP Holdings LLC (200K shares), WOLVERINE ASSET MANAGEMENT LLC (183K shares), KIM, LLC (183K shares), Walleye Capital LLC (168K shares), and PERISCOPE CAPITAL INC. (150K shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.